In mycobacteria, the study of inhibition by metal ions has been limited by the absence of suitable molecular vectors. Recently, we reported on the inhibitory activity of a family of chelators, macrocyclic compounds (MCC), against Mycobacterium tuberculosis. In this study equimolar concentrations of the free cations vanadium(IV), arsenic(III), iron(III), indium(III) and bismuth(III), and as 1:1 complexes with the MCC 1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetra-acetic acid (TETA) were tested in vitro against M. tuberculosis using the Bactece 460 TB radiometric technology (Becton-Dickinson, MD, USA). Radiometric inhibition above 80% was obtained with free indium(III) and bismuth(III), and ranged from 80% to 99%, with the complexes of TETA with vanadium(IV), bismuth(III) and indium(III), in the order of increasing activity. The highest radiometric inhibition levels were obtained with the [In(TETA)] À complex, which caused drops of up to 4 log units in cellular viability. The minimal inhibitory concentration of this compound was evaluated at 3 lM.
Introduction
Metal ions, free or complexed, are known for their disinfectant properties and in some cases as effective therapeutic agents against bacterial diseases. As early as 1908 research in this area resulted in the awarding of the Nobel Prize to Paul Ehrlich for his development of chemotherapeutic arsenical drugs [1] . Before the age of antibiotic therapy, gold compounds were introduced in the treatment of tuberculosis, although their effectiveness against the disease was not scientifically confirmed but initially based on the observation of Robert Koch, who had reported in vitro activity of gold cyanide against Mycobacterium tuberculosis [2] .
In mycobacteria, the study of inhibition by metal ions has been limited by the absence of suitable molecular vectors. Although in non-biological systems mycobacterial siderophores of the mycobactin family are known to form stable complexes with a number of metal ions [3] [4] [5] [6] , attempts at using these siderophores to vectorize cations with potential antimycobacterial activity failed due to their high ferri-specificity [7] . More recently nonsiderophore chelators have been developed and tested against mycobacterial species showing enhanced activity when in the form of complexes [8] [9] [10] [11] [12] [13] [14] [15] . However, it seems clear, that in regards to mycobacterial pathogens the chemotherapeutic potential of metal ions has not been fully explored.
Recently, we reported on the inhibitory activity against M. tuberculosis of chelators belonging to the family of macrocyclic compounds (MCC) [16] . In this study, we explore the in vitro activity against M. tuberculosis of free cations: vanadium(IV), arsenic-(III), iron(III), indium(III) and bismuth(III); and their complexes with the MCC 1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetra-acetic acid (TETA).
Materials and methods

Organisms
The M. tuberculosis H37Rv strain was selected for this study. Prior to the experiments, the strain was precultured in 12B vials for use with the Bactece 460 TB radiometric instrument (Becton-Dickinson, Microbiology Systems, Cockeysville, MD, USA). Otherwise, it was stored as frozen suspensions at À70°C.
Drugs
The compound 1,4,8,11-tetraazacyclotetradecane-1,4, 8,11-tetra-acetic acid (TETA), was synthesized from the MCC cyclam (1,4,8,11-tetraazacyclotetradecane) by condensation with potassium chloroacetate in aqueous basic solution, keeping the pH below 10 and the temperature between 40 and 60°C during the reaction. The mixture was then acidified to pH 2 with hydrochloric acid. The precipitate obtained was recrystallized and identified as pure TETA (Fig. 1) [17] . The final product was characterized by melting point, elemental analysis, 1 H and 13 C NMR. Cyclam was obtained commercially from Strem Chemicals (Bischheim, France).
The standard solution of arsenic(III) was prepared by dissolving a known amount of As 2 O 3 (p.a.) in ionized water, and the solution of oxovanadium(IV) was prepared from V 2 O 5 AE 5H 2 O by dissolving in a solution of H 2 SO 4 and standardized with KMnO 4 . The other metal ions were prepared from nitrate salts, of analytical grade with demineralized water (obtained by a Millipore/ Milli-Q system) and were standardized by titration with K 2 H 2 EDTA solutions as described [18] .
The metal complexes of TETA and vanadium(IV), arsenic(III), iron(III), indium(III) and bismuth(III) were prepared by the addition of aqueous solutions of Fe(NO 3 ) 3 , arsenic(III), vanadium(IV), Bi(NO 3 ) 3 and In(NO 3 ) 3 , to the MCC in a 1:1 ratio, followed by the increase of the pH of the mixture with a solution of KOH till the complete formation of the complex (between pH 4.5 and 6) [19] .
To prepare the TETA complexes and to study the biological effect of the free cations Fe(NO 3 ) 3 , As 2 O 3 , V 2 O 5 , Bi(NO 3 ) 3 and In(NO 3 ) 3 were purchased from Merck (VWR International, Lisbon, Portugal).
Equimolar concentrations, of 116 lM, of the cations, TETA and the TETA complexes were used in the in vitro studies.
Drug sensitivity studies
For examining the antimycobacterial activity of different MCC-metal complexes, stock solutions of 5 mg ml À1 were prepared in sterile distilled water, sterilized by filtration using 0.2 lm Filtropur filters (Sarstedt, Nü mbrecht, Germany), and frozen at À20°C until use. Volumes of 0.1 ml of the appropriate dilutions were injected into Bactece 12B vials (Becton Dickinson, Sparks, MD, USA), to obtain concentrations ranging from 10 to 300 mg L À1 . In vitro activities were evaluated using methodologies applied to the Bactece 460 TB instrument (Becton Dickinson, Sparks, MD, USA), as previously described [16, 20] . This instrument uses the radiometric detection of bacterial growth through the capture and measure of released 14 C-labelled CO 2 resulting from the metabolism of 14 C-labelled palmitic acid by the organisms in the Bactece 12 B growth medium. The 14 C-labelled CO 2 captured by the detector is expressed as a numerical value called the Bactece growth index (GI) which ranges from 1 to 999. As the GI during exponential growth is a measure of respiratory activity that is proportional to the number of viable bacteria in the vials [21] , it was used in this simple relation to express inhibition. Thus, relative growth was calculated in relation to a vial having received the same initial inoculum but no added compound as control, representing 100% of radiometric growth, or 0% of radiometric inhibition. Results were expressed as the average value obtained from the readings of four consecutive days during exponential growth. Since relative growth was calculated on the basis of GI readings, and is therefore in reference to a measure of respiratory activity, it was also compared to bacterial counts carried out at the end of the experiment by plating serial 10-fold dilutions of the bacterial suspensions from the individual Bactece 12B vials onto Middlebrook 7H11 agar plates, results were expressed in CFU ml À1 . Viability was determined from the comparison of CFU ml À1 from individual Bactece vials at the beginning and at the end of the experiments.
Effect of free and complexed indium
To further evaluate the effect of free and complexed indium(III) on the in vitro growth of M. tuberculosis, equimolar concentrations of 116 lM of In(NO 3 ) 3 , TETA and [In(TETA)]
À were added during exponential growth to individual Bactece 12 B vials, having received the same initial inoculum, but no added compound. Thus, compounds were added six days after inoculation and left to incubate at 37°C with the experiment lasting a total of 14 days. Results expressed as the Bactece growth index (GI) and as bacterial counts in CFU ml À1 , represented the average of three independent experiments.
Minimal inhibitory concentrations (MIC) were determined by testing a wide range of concentrations using procedures recommended for the Bactece 460 radiometric system [16, 20] . Briefly, a control was prepared containing a 10 2 dilution of the initial inoculum used in the drug containing vials, termed 1:100 control. When the growth index (GI) of the 1:100 control vial reached 30, the GI was read one additional day. The difference in the GI values (DGI) was calculated for these two days. The MIC, corresponding to the drug concentration resulting in more than 99% of inhibition of the bacterial population, was defined as the lowest concentration amongst those tested for which the DGI of the drug containing vial was less than the DGI of the 1:100 control, obtained from the reading after the GI had reached 30.
Results
Preliminary observations of the effect of equimolar concentrations of 116 lM of the free cations: vanadium(IV), arsenic(III), iron(III), indium(III) and bismuth(III); and their TETA complexes are shown in Table 1 . Calculated on the basis of GI readings, radiometric inhibition levels above 80% were obtained with free indium(III) (88%) and with bismuth(III) (93%), whereas there was no apparent inhibitory activity with arsenic(III), iron(III) and vanadium(IV). For all the cations, radiometric inhibition was enhanced when they were used in the form of complexes. Radiometric inhibition of and above 80% was obtained with the TETA complexes of vanadium(IV) (80%), bismuth(III) (96%) and indium(III) (99%). Important differences in the radiometric inhibition levels between the free and com- . However, the observed differences in radiometric inhibition levels, calculated on the basis of GI readings, were not reflected by the bacterial counts, as there were no marked differences in viability values between the free and complexed forms except in the case of indium(III).
The negative viability values obtained with the [In (TETA)]
À complex, led us to further evaluate the effect of free and complexed indium(III) on the in vitro growth of M. tuberculosis. Results of this evaluation are summarized in Fig. 2 and represent the average of three independent experiments, using equimolar concentrations of 116 lM of the compounds. Drops averaging 
Discussion
In this study, radiometric Bactece methodologies were used to study the in vitro activity against M. tuberculosis of the free cations: vanadium(IV), arsenic(III), iron(III), indium(III) and bismuth(III); and their complexes with the MCC 1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetra-acetic acid (TETA).
For all the cations, radiometric inhibition based on Bactece GI readings, was enhanced when they were used in the complexed form, the highest levels being observed with the [In(TETA)] À complex. The large range in the variation of the radiometric inhibition levels between the free and complexed forms of arsenic(III), iron(III) and vanadium(III), may reflect regulated uptake or possible extrusion mechanisms as regards the free cation. Mycobacteria, especially environmental species, are known to be resistant to heavy metals [22] [23] [24] , although the mechanisms by which this may take place have only recently begun to be explored. The possible role of the M. tuberculosis Mramp, a divalent cation transporter of the Nramp family, in the extrusion of a variety of metal ions, has recently been suggested [25] . Also recent has been the discovery of the SmtB/ArsR family of metalloregulatory transcriptional regulatory proteins in M. tuberculosis [26] [27] [28] . These regulators repress the expression of operons encoding proteins involved in di-and multivalent heavy metal sequestration, transport, export and reduction by binding to the operator promoter regions of genes repressing transcription. However, when their effector binding sites become occupied by metal ions in response to metal toxicity, a conformational change takes place, allowing transcription to proceed [29] . In M. tuberculosis NmtR has been shown to form complexes with Zn(II), Co(II) and Ni(II) [27, 28] and CmtR with Cd(II) and Pb(II) [26] .
Our previous investigations provided evidence that the use of an appropriate molecular vector as the delivery agent may allow bypassing a highly regulated mechanism [30] . Using Mycobacterium aurum as a model, it was suggested that the toxicity of iron(III), observed at concentrations above 5 lM, depended on whether the uptake of the delivery agent was subject to the cells regulatory mechanisms, as in the case of homologous mycobactin, or not, as with heterologous mycobactins or synthetic chelators. Thus, whereas iron starvation is bacteriostatic [31] , iron uptake, when not regulated, is bactericidal, at concentrations as low as 5 lM, as reported.
Another aspect involves the choice of the cations. The cations vanadium(IV), arsenic(III), indium(III) and bismuth(III), are known to affect diverse biological processes in biological systems in some cases competing with iron(III) in vital functions [32] [33] [34] [35] .
Contrary to variation of the radiometric inhibition, there were no marked differences in bacterial viability between the free and complexed forms except in the case of indium(III). The Bactece radiometric GI is a measure of respiratory activity. Thus, although radiometric inhibition levels were calculated on the basis of GI readings, and were therefore in reference to a measure of respiratory activity, these were also compared to cellular viability determined from the comparison bacterial counts in CFU ml À1 from individual Bactece vials at the beginning and at the end of the experiments. In previous investigations using an iron(III) complex of a MCC, it had been concluded, from the comparison of bacterial viability counts to reductions in the GI, that radiometric inhibition was not determined by direct inhibition of the respiratory activity [16] . However, in this study, where a larger number of cations and their TETA complexes were tested, the results showing a degree of radiometric inhibition seemingly high as compared to drops in bacterial viability counts, suggest that the reductions in the GI may in fact be determined by direct inhibition of the respiratory activity, indicating that the arsenic(III) and vanadium(IV) TETA complexes, [Fe(TETA)] À , and possibly [Bi(TETA)] À are likely to be acting as respiratory poisons without direct killing effect. In contrast [In(TETA)] À appears to be bactericidal.
Drops averaging up to 4 log units in cellular viability, observed with the [In (TETA)] À complex, confirmed the in vitro bactericidal effect of this compound on M. tuberculosis. The MIC values for this complex was low, 3 lM, considering no attempts of derivatization of TETA, for improving uptake and in vitro activity against M. tuberculosis were attempted. Macrocyclic compounds (MCC) seem a promising tool in drug development based on the fact that their properties can be changed considerably by modifying the backbone or by introducing N-substituents [17, 36, 37] . In addition, they already have medical applications as contrastenhancing agents for magnetic resonance imaging (MRI), in nuclear medicine for radioimmunoscintigraphy or radioimmunotherapy and in chelation therapy [38] [39] [40] [41] [42] .
The results presented in this investigation provide evidence that cations may be useful against mycobacterial infections when appropriate molecular vectors are provided and, that the macrocyclic family of compounds seem promising chelators to use in their molecular vectorization. Further studies should also include the evaluation and improvement of intracellular uptake of the MCC chelators, testing the complexes for intramacrophagic clearance of mycobacterial infections and the elucidation of their mechanisms of action in mycobacterial species.
